bisindolylmaleimide i has been researched along with Leukemia, Erythroblastic, Acute in 2 studies
bisindolylmaleimide I: a bis(indolyl)maleimide
Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, Y | 1 |
| Martin, JF | 1 |
| Vainchenker, W | 1 |
| Erusalimsky, JD | 1 |
| Rinaldi, M | 1 |
| Barrera, G | 1 |
| Aquino, A | 1 |
| Spinsanti, P | 1 |
| Pizzimenti, S | 1 |
| Farace, MG | 1 |
| Dianzani, MU | 1 |
| Fazio, VM | 1 |
2 other studies available for bisindolylmaleimide i and Leukemia, Erythroblastic, Acute
| Article | Year |
|---|---|
Inhibition of protein kinase C suppresses megakaryocytic differentiation and stimulates erythroid differentiation in HEL cells.
Topics: Aphidicolin; Biomarkers; Blood Proteins; Cell Cycle; Cell Differentiation; Enzyme Inhibitors; Erythr | 1996 |
4-Hydroxynonenal-induced MEL cell differentiation involves PKC activity translocation.
Topics: Aldehydes; Animals; Biological Transport, Active; Cell Differentiation; Cell Division; Dimethyl Sulf | 2000 |